Himalayas-1 protocol: age, performance status, and organ function
Himalayas-1 protocol exclusion: brain metastases
Himalayas-1 protocol exclusion: cardiovascular disease, recent radiotherapy, and gastrointestinal disease
Phase 1b protocol exclusion: cardiac disease
Phase 1b protocol exclusion: viral infection
Phase 1b protocol exclusion: malabsorption and central nervous system metastases
Renal impairment: darolutamide, the combination partner
Hepatic impairment: darolutamide, the combination partner
Geriatric use: darolutamide, the combination partner
Males of reproductive potential: darolutamide, the combination partner